brain

brain illustration
January 14, 2013

AstraZeneca, VU collaborate to develop new treatments for major brain disorders

AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

By Bill Snyder
December 21, 2012

Low prenatal alcohol’s brain impact

Even relatively low levels of in utero alcohol exposure impact fetal brain development, and the effects last into adulthood, study finds.

By VUMC News and Communications
October 11, 2012

Collaborative effort focuses on pediatric traumatic brain injury

Vanderbilt’s Bill Wilkerson Center and the Department of Hearing and Speech Sciences are offering new interdisciplinary outpatient programs for children ages 3 to 21 who have experienced a traumatic brain injury (TBI).

By Craig Boerner
October 11, 2012

Amish aid search for Alzheimer’s genes

An analysis of Amish populations revealed novel risk genes for late-onset Alzheimer disease.

By Leigh MacMillan
September 7, 2012

Parkinson’s therapy may impact language

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.

By VUMC News and Communications
August 23, 2012

Gregory joins CDC brain injury panel

Andrew Gregory, M.D., associate professor of Orthopaedic Surgery and Rehabilitation, will play a key role in improving the clinical care of youth with mild traumatic brain injury (TBI).

By VUMC News and Communications
July 30, 2012

Concussion testing for young athletes

The Vanderbilt Sports Concussion Center is now offering pre-concussion baseline testing to all community recreational athletes, in advance of many high-impact seasonal sports resuming this fall.
By VUMC News and Communications
July 17, 2012

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
By Leigh MacMillan
July 3, 2012

Receptor’s role in nutrition brain circuitry

New findings point to brain circuitry that communicates about the body’s nutritional status and regulates how nutrients are mobilized.
By Leigh MacMillan
June 27, 2012

Probing the roots of depression by tracking serotonin regulation at a new level

An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail.
June 14, 2012

Roots of childhood brain tumors

Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.
By Leigh MacMillan
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
By Bill Snyder
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
By VUMC News and Communications